Listen to the article
GLP-1 Drugs Show Promise Beyond Weight Loss, But Experts Warn of Common Mistakes
GLP-1 drugs (glucagon-like peptide-1s) have surged in popularity in recent years, initially as diabetes management tools before gaining widespread attention for weight loss applications. Now, emerging research suggests these medications – which include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) – may offer additional health benefits, particularly for cardiovascular and kidney function.
Dr. Meena T. Malhotra, a functional medicine doctor and weight-loss specialist near Chicago, has observed numerous health improvements in patients taking GLP-1s, especially those with diabetes who were previously struggling.
“We observed that this sick population was doing better than the diabetics who were on other diabetes medicines,” she noted, citing improvements in brain health, memory, heart function, circulation, and liver and kidney function. “We realized there was more to the drug than just sugar control and weight loss.”
These medications work by slowing gastric emptying, reducing appetite and improving insulin signaling. While many patients can safely use GLP-1s – even in smaller “microdoses” according to some practitioners – Malhotra warns that several common mistakes may undermine their effectiveness or create new health problems.
Starting Medication Before Lifestyle Changes
Medical experts broadly agree that anyone considering GLP-1 drugs should first focus on adopting healthier habits. Malhotra recommends improving basic nutrition by increasing intake of whole, minimally processed foods and prioritizing protein and fiber to support satiety and gut health.
Even modest dietary improvements can lead to initial weight loss, reduced fluid retention and better insulin sensitivity before medication is introduced. Once GLP-1 treatment begins, these lifestyle modifications may reduce the necessary dosage, minimize side effects, and help preserve lean muscle mass.
“If you are decreasing the calories but not fixing the nutritional foundation, you will lose lean mass,” Malhotra cautioned. “But if you’re eating a balanced diet with adequate protein and doing strength training with a smaller dose of the drug, you will get better results and your health will improve.”
Skipping Proper Medical Evaluation
The growing trend of obtaining GLP-1 medications online without proper medical supervision poses serious health risks, according to Malhotra.
“Nobody examines the patient – they just fill out a form and the medicine shows up at their door,” she said, emphasizing that patients should undergo a thorough examination and bloodwork before starting these drugs.
“If something is off, it needs to be addressed,” she added. “Whether it’s a thyroid issue, a heart condition or another factor slowing your metabolism, any underlying problems should be fixed first.”
Malhotra recommends monthly check-ins during treatment to ensure patients are losing fat rather than muscle mass. “That’s very important, because if you lose lean mass, your body is not getting healthier,” she explained. These regular evaluations also help confirm that patients are maintaining balanced nutrition and adhering to strength training protocols.
Insufficient Protein Intake
One critical mistake patients make while taking GLP-1s is reducing calories without ensuring adequate protein consumption. Most adults need approximately 0.5 to 0.8 grams of protein per pound of body weight daily to maintain muscle health – translating to 100-160 grams for a 200-pound person. Those who are physically active may require even higher amounts.
“The amount of protein you need will depend on the frequency and intensity of your workouts,” Malhotra explained. Without sufficient protein, patients risk losing valuable muscle mass rather than primarily body fat.
Increasing Doses Too Quickly
Patient impatience often leads to prematurely increasing medication dosages in pursuit of faster results, which can trigger serious complications.
“You may start to see results within the first week or month, but some people do need a higher dose over time,” Malhotra said. “The key is to be patient and increase it gradually — typically month by month.”
She recommends waiting at least a month before adjusting dosages, even if initial results seem modest. “That’s a recipe for problems, including side effects like pancreatitis,” she warned about rapid dose escalation. “Your body needs time to adjust and adapt.”
Malhotra advises a measured approach: “You can go up if you hit a plateau or if it’s not helping, but we usually wait a month to increase the dose.”
Poor Side Effect Management
While building a strong health foundation can prevent many complications, some side effects remain common with GLP-1 medications. Malhotra recommends eating smaller, more frequent meals – approximately fist-sized portions – rather than large ones.
Keeping fat intake moderate is also important, as these medications already slow stomach emptying, and dietary fat can further delay the process, potentially worsening nausea.
For digestive issues, simple interventions can prove effective. Some patients find ginger helpful for nausea, while incorporating more liquids – such as broths, soups and protein shakes – can be gentler on the stomach. Prunes and other fiber-rich foods may help prevent constipation, a common side effect.
“These little lifestyle hacks can help a lot with managing the side effects, instead of stopping and then finding that your weight is yo-yoing,” Malhotra concluded.
As GLP-1 medications continue gaining popularity, proper medical oversight, lifestyle modifications, and careful adherence to dosing protocols remain essential for maximizing their benefits while minimizing potential risks.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


27 Comments
Production mix shifting toward Health might help margins if metals stay firm.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on 5 Critical Mistakes Weight-Loss Drug Patients Make, Doctor Warns. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Production mix shifting toward Health might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.